Jiuzhitang Co., Ltd. (SHE:000989)
China · Delayed Price · Currency is CNY 8.23
-0.10 (-1.20%)
Nov 13, 2026, 3:04 PM CST
Jiuzhitang Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,788 | 2,229 | 2,371 | 2,961 | 3,033 | 3,784 |
Revenue Growth | 44.06% | -5.99% | -19.91% | -2.38% | -19.84% | 6.31% |
Gross Profit Gross Profit Growth | 1,664 | 1,330 | 1,386 | 1,786 | 1,775 | 2,224 |
Operating Income Operating Income Growth | 532.32 | 248.12 | 168.72 | 282.07 | 233.26 | 379.9 |
Net Income Net Income Growth | 374.63 | 222.6 | 216.2 | 297.41 | 357.99 | 270.7 |
Earnings Per Share EPS Growth | 0.44 | 0.26 | 0.25 | 0.35 | 0.42 | 0.32 |
EPS Growth | 194.07% | 3.42% | -26.82% | -16.91% | 32.05% | -2.31% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Business Pharmaceutical Business Growth | 72.26 | 69.96 | 71.66 | 473.53 | 1,041 |
Unallocated Other Business Unallocated Other Business Growth | - | 8.42 | 23.86 | 17.25 | 25.99 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 2,812 | 2,293 | 2,866 | 2,542 | 2,717 |
Inter Segment Elimination Inter Segment Elimination Growth | -670.58 | - | - | - | - |
Total Total Growth | 2,214 | 2,371 | 2,961 | 3,033 | 3,784 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,190 | 911.61 | 892.88 | 903.92 | 1,089 | 808.08 |
Total Debt Total Debt Growth | 38.33 | 83.89 | 53.01 | 129.85 | 86.6 | 106.04 |
Net Cash (Debt) Net Cash Growth | 1,152 | 827.72 | 839.87 | 774.06 | 1,003 | 702.04 |
Net Cash Growth | 26.78% | -1.45% | 8.50% | -22.81% | 42.83% | -29.39% |
Net Cash Per Share Net Cash Per Share Growth | 1.36 | 0.98 | 0.99 | 0.90 | 1.17 | 0.82 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 692.66 | 426.27 | 198.96 | 108.64 | 499.13 | 365.91 |
Capital Expenditures CapEx Growth | -75.86 | -39.95 | -72.22 | -72.84 | -96.83 | -207.32 |
Free Cash Flow Free Cash Flow Growth | 616.8 | 386.32 | 126.73 | 35.79 | 402.3 | 158.6 |
Free Cash Flow Growth | 16.14% | 204.82% | 254.06% | -91.10% | 153.67% | -70.00% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 59.67% | 59.65% | 58.46% | 60.31% | 58.51% | 58.77% |
Operating Margin | 19.09% | 11.13% | 7.12% | 9.53% | 7.69% | 10.04% |
Pretax Margin | 21.51% | 13.79% | 10.65% | 11.84% | 14.99% | 9.43% |
Profit Margin | 13.44% | 9.99% | 9.12% | 10.04% | 11.80% | 7.15% |
FCF Margin | 22.12% | 17.33% | 5.34% | 1.21% | 13.26% | 4.19% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.300 | 0.300 | 0.400 | 0.400 | 0.400 |
Dividend Per Share Growth | 0% | 0% | -25.00% | 0% | 0% | 0% |
Dividend Yield | 3.65% | 3.44% | 3.77% | 3.95% | 4.54% | 3.68% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 18.60 | 33.19 | 31.17 | 29.13 | 21.07 | 34.34 |
Forward PE | - | 35.09 | 35.09 | 35.09 | 35.09 | 35.09 |
P/FCF Ratio | 11.29 | 19.12 | 53.17 | 242.00 | 18.74 | 58.61 |
PS Ratio | 2.50 | 3.31 | 2.84 | 2.93 | 2.49 | 2.46 |